FDA Approves Nexium I.V. (Esomeprazole Sodium) for the Treatment of Gastroesophageal Reflux Disease (GERD) With Erosive Esophagitis in Pediatric and Adolescent Patients
Links shared publicly online about this topic.
- 321total visits
FDA Approves Nexium I.V. (Esomeprazole Sodium) for the Treatment of Gastroesophageal Reflux Disease (GERD) With Erosive Esophagitis in Pediatric and Adolescent Patients
Nexium I.V. (esomeprazole sodium) is used to treat gastroesophageal reflux disease (GERD) with erosive esophagitis in pediatric and adolescent patients. Includes Nexium I.V.side effects, interactions and indications.
View full resource at drugs.com
Tags: GERD Medication, Zollinger-Ellison Syndrome Medication, Heartburn Medication, H pylori Infection Medication, Erosive Esophagitis Medication, Stomach Ulcer Medication, FDA, Nexium
Most Recently Shared on May 3, 2011 at 2:10 am By:
FDA Approves Nexium I.V. (Esomeprazole Sodium) for the Treatment of Gastroesophageal Reflux Disease (GERD)... http://bit.ly/jMA3xK #drug
Advertisement
